More on MNOV
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.52 |
|
|||
| Open | $2.84 | ||||
| 52 Wk High | $10.16 | ||||
| 52 Wk Low | $2.91 | ||||
| Day High | $3.90 | ||||
| Day Low | $2.83 | ||||
| P/E | N/A | ||||
| EPS | $-0.41 | ||||
| Volume | 7,389,313 | ||||
- Roth/MKM Starts MediciNova (MNOV) at Buy
- MediciNova to Participate in Two Investor Conferences in September
- Form 8-K MEDICINOVA INC For: Aug 17
- Form 10-Q MEDICINOVA INC For: Jun 30
- MediciNova reaches 200-patient enrollment in NIH-funded ALS study
- MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients
- MediciNova completes last patient visit in NAFLD Phase 2 trial
- MediciNova CEO Provides Shareholder Update
- Form 4 MEDICINOVA INC For: Jun 23 Filed by: Nagao Hideki
- Form 4 MEDICINOVA INC For: Jun 23 Filed by: Lemerond Nicole
Entities mentioned with MNOV
- FDA | View Related Stories »
- Ladenburg Thalmann Financial Services | View Related Stories »
- Earnings | View Related Stories »
- Pre Market Movers | View Related Stories »
- S3 | View Related Stories »
- Definitive Agreement | View Related Stories »
- B. Riley | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
